Advertisement
Singapore markets closed

  • Straits Times Index

    3,300.00
    -4.00 (-0.12%)
     

  • S&P 500

    5,497.75
    +10.72 (+0.20%)
     

  • Dow

    38,909.22
    +74.36 (+0.19%)
     

  • Nasdaq

    17,899.66
    +37.43 (+0.21%)
     

  • Bitcoin USD

    64,927.89
    +41.02 (+0.06%)
     

  • CMC Crypto 200

    1,347.58
    -35.09 (-2.54%)
     

  • FTSE 100

    8,260.96
    +55.85 (+0.68%)
     

  • Gold

    2,376.00
    +29.10 (+1.24%)
     

  • Crude Oil

    82.24
    +0.67 (+0.82%)
     

  • 10-Yr Bond

    4.2830
    +0.0660 (+1.56%)
     

  • Nikkei

    38,633.02
    +62.26 (+0.16%)
     

  • Hang Seng

    18,335.32
    -95.07 (-0.52%)
     

  • FTSE Bursa Malaysia

    1,592.69
    -7.10 (-0.44%)
     

  • Jakarta Composite Index

    6,819.32
    +92.40 (+1.37%)
     

  • PSE Index

    6,344.56
    -21.47 (-0.34%)
     

Walgreens shelves plans for Boots IPO, Bloomberg News reports

Reuters
·1-min read
Walgreens brand Allergy Nasal Spray, owned by the Walgreens Boots Alliance, Inc., is seen for sale in Manhattan, New York City

(Reuters) - Walgreens Boots Alliance has shelved plans for a potential initial public offering of its UK-based Boots drugstore chain as sale talks continue, Bloomberg News reported on Friday citing people with knowledge of the matter.

The pharmacy chain is now exploring other options for Boots and has continued informal talks with potential buyers, including private equity firms, in recent weeks, according to the report.

Deliberations are ongoing and Walgreens has made no final decisions on its future ownership of Boots, the report added.

Last month, Bloomberg News had reported any deal for Boots would value it at around 7 billion pounds.

ADVERTISEMENT

In 2022, Walgreens had scrapped preliminary plans to sell the unit. However, it revived discussions on separating Boots, including the possibility of an IPO in London, late last year.

($1 = 0.7860 pounds)

(Reporting by Puyaan Singh in Bengaluru; Editing by Krishna Chandra Eluri)